Aardvark Therapeutics (AARD) Earnings Date & Reports

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AARD is expected to report earnings to rise 6.67% to -80 cents per share on April 06

Aardvark Therapeutics AARD Stock Earnings Reports

Q4'25

Est.

$-0.80

Q3'25

Beat

by $0.02

Q2'25

Beat

by $0.04

The last earnings report on November 13 showed earnings per share of -75 cents, beating the estimate of -76 cents. With 134.62K shares outstanding, the current market capitalization sits at 335.09M.

View a ticker or compare two or three

Compare

AARD

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AARD showed earnings on November 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading for AARD

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details